www.fgks.org   »   [go: up one dir, main page]

Press Enter or click the Search button above to view results.

Recent Drug Updates

  • guselkumab (Tremfya) FDA approved for moderate-to-severe chronic plaque psoriasis in patients who are candidates for systemic therapy or phototherapy
  • glutamine (Endari) FDA approves for reducing severe complications associated with sickle cell disease
  • abatacept (Orencia) New indication approved for psoriatic arthritis
  • daratumumab (Darzalex) FDA approved daratumumab in combination with pomalidomide and dexamethasone for patients with multiple myeloma
  • c1 inhibitor human (Haegarda) FDA approved first subcutaneous c1 inhibitor to prevent hereditary angioedema attacks in adolescents and adults
  • dabrafenib (Tafinlar) FDA approved dabrafenib in combination with trametinib for metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation